Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cell and Tissue Therapies WA (CTTWA) is a premier Australian facility specializing in the manufacture of cell-based therapies for clinical use. Operating under the North Metropolitan Health Service, it provides Good Manufacturing Practice (GMP) certified services for the processing and storage of hematopoietic stem cells and other advanced cellular therapeutics. The organization supports both routine clinical treatments, such as bone marrow transplants, and cutting-edge clinical trials involving CAR-T cells and mesenchymal stromal cells. CTTWA serves as a critical hub for regenerative medicine and cellular immunotherapy in Western Australia, bridging the gap between laboratory research and patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cell and Tissue Therapies.